{"name":"IBON JAUNARENA","slug":"ibon-jaunarena","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Control hemipelvis","genericName":"Control hemipelvis","slug":"control-hemipelvis","indication":"Control of hemipelvis movement","status":"phase_3"},{"name":"Fibrin sealant hemipelvis","genericName":"Fibrin sealant hemipelvis","slug":"fibrin-sealant-hemipelvis","indication":"Hemostasis in hemipelvis surgical procedures","status":"phase_3"}]}],"pipeline":[{"name":"Control hemipelvis","genericName":"Control hemipelvis","slug":"control-hemipelvis","phase":"phase_3","mechanism":"This drug targets the hemipelvis to control its movement.","indications":["Control of hemipelvis movement"],"catalyst":""},{"name":"Fibrin sealant hemipelvis","genericName":"Fibrin sealant hemipelvis","slug":"fibrin-sealant-hemipelvis","phase":"phase_3","mechanism":"Fibrin sealant forms a hemostatic plug by cross-linking fibrin and thrombin to achieve rapid hemostasis at surgical sites.","indications":["Hemostasis in hemipelvis surgical procedures"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}